Literature DB >> 12932118

Differential FDG accumulation associated with GLUT-1 expression in a patient with lymphoma.

Hirofumi Koga1, Yoshio Matsuo, Masayuki Sasaki, Makoto Nakagawa, Koichiro Kaneko, Kazutaka Hayashi, Yasuo Kuwabara, Hiroshi Honda.   

Abstract

We herein report a case of malignant lymphoma that showed differential FDG accumulation associated with the degree of glucose transporter 1 (GLUT-1) expression. For clinical staging purpose, FDG-PET was performed on a 47-year-old male who had been diagnosed to have malignant lymphoma, diffuse medium B-cell type. Although an X-ray CT showed multiple and bulky lymphadenopathy including bilateral submandibular, deep cervical, supraclavicular, axillar, hilar, mesenteric and paraaortic regions, FDG-PET showed a high accumulation only in the bilateral submandibular and deep cervical region. An immunohistochemical analysis demonstrated a high GLUT-1 expression in the right cervical lymph node, which showed a high FDG uptake. On the other hand, a bone marrow specimen with diffuse lymphoma cell involvement indicated showed no FDG accumulation and also revealed a negative GLUT-1 expression. This case suggests that the differential FDG accumulation shown by lesions is associated with the degree of GLUT-1 expression in patients with lymphoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12932118     DOI: 10.1007/bf02988530

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  5 in total

1.  Dual time-point FDG PET/CT and FDG uptake and related enzymes in lymphadenopathies: preliminary results.

Authors:  Sofie Bæk Christlieb; Casper Nørgaard Strandholdt; Birgitte Brinkmann Olsen; Karen Juul Mylam; Thomas Stauffer Larsen; Anne Lerberg Nielsen; Max Rohde; Oke Gerke; Karen Ege Olsen; Michael Boe Møller; Bjarne Winther Kristensen; Niels Abildgaard; Abass Alavi; Poul Flemming Høilund-Carlsen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-04-22       Impact factor: 9.236

2.  Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer.

Authors:  Jinyu Gu; Hirofumi Yamamoto; Hiroki Fukunaga; Katsuki Danno; Ichiro Takemasa; Masataka Ikeda; Mitsuaki Tatsumi; Mitsugu Sekimoto; Jun Hatazawa; Tsunehiko Nishimura; Morito Monden
Journal:  Dig Dis Sci       Date:  2006-11-02       Impact factor: 3.199

3.  18F-FDG uptake in primary gastric malignant lymphoma correlates with glucose transporter 1 expression and histologic malignant potential.

Authors:  Yuko Watanabe; Hiroaki Suefuji; Yasumitsu Hirose; Hayato Kaida; Gen Suzuki; Jun Uozumi; Etsuyo Ogo; Mayumi Miura; Konomi Takasu; Kanoko Miyazaki; Keita Nakahara; Masatoshi Ishibashi; Takashi Okamura; Koichi Ohshima; Naofumi Hayabuchi
Journal:  Int J Hematol       Date:  2012-12-02       Impact factor: 2.490

Review 4.  Positron emission tomography in renal cell carcinoma: an imaging biomarker in development.

Authors:  Amir H Khandani; W Kimryn Rathmell
Journal:  Semin Nucl Med       Date:  2012-07       Impact factor: 4.802

5.  Correlation of pretreatment 18F-FDG uptake with clinicopathological factors and prognosis in patients with newly diagnosed diffuse large B-cell lymphoma.

Authors:  Honghui Huang; Fei Xiao; Xiaofeng Han; Lu Zhong; Hua Zhong; Lan Xu; Jianyi Zhu; Beiwen Ni; Jia Liu; Yi Fang; Minyue Zhang; Lijing Shen; Ting Wang; Jianjun Liu; Yiping Shi; Yumei Chen; Luying Zheng; Qiang Liu; Fangyuan Chen; Jianmin Wang
Journal:  Nucl Med Commun       Date:  2016-07       Impact factor: 1.690

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.